Export 254 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is S  [Clear All Filters]
2022
D. J. Williams, C Creech, B., Walter, E. B., Martin, J. M., Gerber, J. S., Newland, J. G., Howard, L., Hofto, M. E., Staat, M. A., Oler, R. E., Tuyishimire, B., Conrad, T. M., Lee, M. S., Ghazaryan, V., Pettigrew, M. M., Fowler, V. G., Chambers, H. F., Zaoutis, T. E., Evans, S., and W Huskins, C., “Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial.”, JAMA Pediatr, vol. 176, no. 3, pp. 253-261, 2022.
2021
F. Scaggs Huang, Bernstein, D. I., Slobod, K. S., Portner, A., Takimoto, T., Russell, C. J., Meagher, M., Jones, B. G., Sealy, R. E., Coleclough, C., Branum, K., Dickey, M., Buschle, K., McNeal, M., Makowski, M., Nakamura, A., and Hurwitz, J. L., “Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults.”, Hum Vaccin Immunother, vol. 17, no. 2, pp. 554-559, 2021.
E. V. Millar, Bennett, J. W., Barin, B., Carey, P. M., Law, N. N., English, C. E., Schwartz, M. M., Cochrane, T., Ellis, M. W., Tribble, D. R., M Cooke, T., and Hennessey, J. P., “Safety, Immunogenicity, And Efficacy Of Ndv-3a Against Staphylococcus Aureus Colonization: A Phase 2 Vaccine Trial Among Us Army Infantry Trainees”, Vaccine, vol. 39, no. 23, pp. 3179-3188, 2021.
I. U. Scott, Oden, N. L., VanVeldhuisen, P. C., Ip, M. S., and Blodi, B. A., “SCORE2 Report 17: Macular Thickness Fluctuations in anti-VEGF-Treated Patients with Central or Hemiretinal Vein Occlusion”, Graefes Arch Clin Exp Ophthalmol, 2021.
2020
E. J. Anderson, Rouphael, N. G., Widge, A. T., Jackson, L. A., Roberts, P. C., Makhene, M., Chappell, J. D., Denison, M. R., Stevens, L. J., Pruijssers, A. J., McDermott, A. B., Flach, B., Lin, B. C., Doria-Rose, N. A., O'Dell, S., Schmidt, S. D., Corbett, K. S., Swanson, P. A., Padilla, M., Neuzil, K. M., Bennett, H., Leav, B., Makowski, M., Albert, J., Cross, K., Edara, V. Viswanadh, Floyd, K., Suthar, M. S., Martinez, D. R., Baric, R., Buchanan, W., Luke, C. J., Phadke, V. K., Rostad, C. A., Ledgerwood, J. E., Graham, B. S., and Beigel, J. H., “Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.”, N Engl J Med, 2020.
F. M. Munoz, Patel, S. M., Jackson, L. A., Swamy, G. K., Edwards, K. M., Frey, S. E., Petrie, C. R., Sendra, E. A., and Keitel, W. A., “Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants.”, Vaccine, vol. 38, no. 33, pp. 5355-5363, 2020.
A. Hendrick, VanVeldhuisen, P. C., Scott, I. U., King, J., Blodi, B. A., Ip, M. S., Khurana, R. N., and Oden, N. L., “SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes With Central or Hemiretinal Vein Occlusion Managed With Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical Trials.”, Am J Ophthalmol, vol. 222, pp. 185-193, 2020.
T. Etheridge, Blodi, B., Oden, N., Van Veldhuisen, P., Scott, I. U., Ip, M. S., Mititelu, M., and Domalpally, A., “Spectral Domain Optical Coherence Tomography Predictors of Visual Acuity in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2).”, Ophthalmol Retina, 2020.
J. B. Patel, Wilson, S. H., Oakes, T. R., Santhanam, P., and Weaver, L. K., “Structural and Volumetric Brain MRI Findings in Mild Traumatic Brain Injury.”, AJNR Am J Neuroradiol, vol. 41, no. 1, pp. 92-99, 2020.
2019
S. A. Jongo, Church, L. W. Preston, Mtoro, A. T., Chakravarty, S., Ruben, A. J., Swanson, P. A., Kassim, K. R., Mpina, M., Tumbo, A. - M., Milando, F. A., Qassim, M., Juma, O. A., Bakari, B. M., Simon, B., James, E. R., Abebe, Y., Kc, N., Saverino, E., Gondwe, L., Studer, F., Fink, M., Cosi, G., El-Khorazaty, J., Styers, D., Seder, R. A., Schindler, T., Billingsley, P. F., Daubenberger, C., B Sim, K. Lee, Tanner, M., Richie, T. L., Abdulla, S., and Hoffman, S. L., “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
S. A. Jongo, Church, L. W. Preston, Mtoro, A. T., Chakravarty, S., Ruben, A. J., Swanson, P. A., Kassim, K. R., Mpina, M., Tumbo, A. - M., Milando, F. A., Qassim, M., Juma, O. A., Bakari, B. M., Simon, B., James, E. R., Abebe, Y., Kc, N., Saverino, E., Gondwe, L., Studer, F., Fink, M., Cosi, G., El-Khorazaty, J., Styers, D., Seder, R. A., Schindler, T., Billingsley, P. F., Daubenberger, C., B Sim, K. Lee, Tanner, M., Richie, T. L., Abdulla, S., and Hoffman, S. L., “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
S. A. Jongo, Church, L. W. Preston, Mtoro, A. T., Chakravarty, S., Ruben, A. J., Swanson, P. A., Kassim, K. R., Mpina, M., Tumbo, A. - M., Milando, F. A., Qassim, M., Juma, O. A., Bakari, B. M., Simon, B., James, E. R., Abebe, Y., Kc, N., Saverino, E., Gondwe, L., Studer, F., Fink, M., Cosi, G., El-Khorazaty, J., Styers, D., Seder, R. A., Schindler, T., Billingsley, P. F., Daubenberger, C., B Sim, K. Lee, Tanner, M., Richie, T. L., Abdulla, S., and Hoffman, S. L., “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
S. A. Jongo, Church, L. W. Preston, Mtoro, A. T., Chakravarty, S., Ruben, A. J., Swanson, P. A., Kassim, K. R., Mpina, M., Tumbo, A. - M., Milando, F. A., Qassim, M., Juma, O. A., Bakari, B. M., Simon, B., James, E. R., Abebe, Y., Kc, N., Saverino, E., Gondwe, L., Studer, F., Fink, M., Cosi, G., El-Khorazaty, J., Styers, D., Seder, R. A., Schindler, T., Billingsley, P. F., Daubenberger, C., B Sim, K. Lee, Tanner, M., Richie, T. L., Abdulla, S., and Hoffman, S. L., “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
J. M. Marrazzo, Dombrowski, J. C., Wierzbicki, M. R., Perlowski, C., Pontius, A., Dithmer, D., and Schwebke, J., “Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial.”, Clin Infect Dis, vol. 68, no. 5, pp. 803-809, 2019.
T. A. Crowell, Colby, D. J., Pinyakorn, S., Sacdalan, C., Pagliuzza, A., Intasan, J., Benjapornpong, K., Tangnaree, K., Chomchey, N., Kroon, E., de Souza, M. S., Tovanabutra, S., Rolland, M., Eller, M. A., Paquin-Proulx, D., Bolton, D. L., Tokarev, A., Thomas, R., Takata, H., Trautmann, L., Krebs, S. J., Modjarrad, K., McDermott, A. B., Bailer, R. T., Doria-Rose, N., Patel, B., Gorelick, R. J., Fullmer, B. A., Schuetz, A., Grandin, P. V., O'Connell, R. J., Ledgerwood, J. E., Graham, B. S., Tressler, R., Mascola, J. R., Chomont, N., Michael, N. L., Robb, M. L., Phanuphak, N., and Ananworanich, J., “Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial.”, Lancet HIV, vol. 6, no. 5, pp. e297-e306, 2019.
H. M. El Sahly, Atmar, R. L., Patel, S. M., Bellamy, A., Liu, L., Hong, W., Zhu, H., Guan, Y., and Keitel, W. A., “Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination.”, Vaccine, vol. 37, no. 19, pp. 2561-2568, 2019.
K. Modjarrad, Roberts, C. C., Mills, K. T., Castellano, A. R., Paolino, K., Muthumani, K., Reuschel, E. L., Robb, M. L., Racine, T., Oh, M. - D., Lamarre, C., Zaidi, F. I., Boyer, J., Kudchodkar, S. B., Jeong, M., Darden, J. M., Park, Y. K., Scott, P. T., Remigio, C., Parikh, A. P., Wise, M. C., Patel, A., Duperret, E. K., Kim, K. Y., Choi, H., White, S., Bagarazzi, M., May, J. M., Kane, D., Lee, H., Kobinger, G., Michael, N. L., Weiner, D. B., Thomas, S. J., and Maslow, J. N., “Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.”, Lancet Infect Dis, vol. 19, no. 9, pp. 1013-1022, 2019.
C. Carter, Houser, K. V., Yamshchikov, G. V., Bellamy, A. R., May, J., Enama, M. E., Sarwar, U., Larkin, B., Bailer, R. T., Koup, R., Chen, G. L., Patel, S. M., Winokur, P., Belshe, R., Dekker, C. L., Graham, B. S., and Ledgerwood, J. E., “Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial.”, PLoS One, vol. 14, no. 9, p. e0222178, 2019.
F. M. Munoz, Anderson, E. J., Bernstein, D. I., Harrison, C. J., Pahud, B., Anderson, E., C Creech, B., Berry, A. A., Kotloff, K. L., Walter, E. B., Atmar, R. L., Bellamy, A. R., Chang, S., and Keitel, W. A., “Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents.”, Vaccine, vol. 37, no. 36, pp. 5161-5170, 2019.
T. L. Schonfeld, Brown, J. S., N Amoura, J., and Gordon, B. G., “Strength through Structure: Defending a Structured Approach to Contraceptive Mandates in Clinical Research.”, Ethics Hum Res, vol. 41, no. 3, pp. 33-35, 2019.
D. Collie, Gay, K., Sheikh, M., Esterlitz, J., Saver, J., Warach, S., and Janis, Son behalf, “Stroke Version 2.0 Common Data Element (CDE) Review: Updates to the National Institute of Neurological Disorders and Stroke (NINDS) CDEs for Stroke”, in American Academy of Neurology 71st Annual Meeting, Philadelphia, PA, 2019.
M. S. Natrajan, Rouphael, N., Lai, L., Kazmin, D., Jensen, T. L., Weiss, D. S., Ibegbu, C., Sztein, M. B., Hooper, W. F., Hill, H., Anderson, E. J., Johnson, R., Sanz, P., Pulendran, B., Goll, J. B., and Mulligan, M. J., “Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses.”, Vaccines (Basel), vol. 8, no. 1, 2019.
2018
F. M. Munoz, Jackson, L. A., Swamy, G. K., Edwards, K. M., Frey, S. E., Stephens, I., Ault, K., Winokur, P., Petrie, C. R., Wolff, M., Patel, S. M., and Keitel, W. A., “Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women.”, Vaccine, vol. 36, no. 52, pp. 8054-8061, 2018.
R. A. Annunziato, Bucuvalas, J. C., Yin, W., Arnand, R., Alonso, E. M., Mazariegos, G. V., Venick, R. S., Stuber, M. L., Shneider, B. L., and Shemesh, E., “Self-Management Measurement and Prediction of Clinical Outcomes in Pediatric Transplant.”, J Pediatr, vol. 193, pp. 128-133.e2, 2018.
H. S. L. Jim, Sutton, S., Majhail, N. S., Wood, W. A., Jacobsen, P. B., Wingard, J. R., Wu, J., Knight, J. M., Syrjala, K. L., and Lee, S. J., “Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation: a secondary data analysis from the BMT CTN 0902 trial.”, Bone Marrow Transplant, vol. 53, no. 8, pp. 1038-1043, 2018.